A large, multiyear study conducted by Illumina, Providence, and Microsoft Research has shown that a comprehensive genomic profiling (CGP) panel, which can assess more than 500 genetic variations in ...

Rznomics, Inc. announced to secure its expanded access program (EAP) from the United States Food and Drug Administration (FDA) for RZ-001, ...

Gene Synthesis Market. The global gene synthesis market is poised for extraordinary expansion, with its valuation projected ...

Seemal Desai, M.D., FAAD, discusses how treatment safety and effectiveness must be carefully evaluated through monitoring ...

The Delhi High Court sought the Centre’s response on Monday on a plea moved by a girl suffering from a rare disease, seeking ...

Ractigen's RAG-21, a treatment for ALS linked to mutations in the FUS gene, has been granted orphan drug designation in the U ...

CRISPR gene editing based treatment reduced HAE attacks rates by up to 80%. NTLA-2002 was well tolerated by patients. The ...

Capsida Biotherapeutics ("Capsida"), a leading fully integrated next-generation gene therapy company developing treatments ...

Global Hemophilia B Treatment Market Expected to Taste Huge Growth with Emerging Innovations into the New Treatment RegimentRockville, MD, Nov. 25, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...

Kanglin Biotech is a China based company, focusing on the research, development and commercialization of first-in-class and best-in-class gene therapy drugs, most of which are targeted at diseases ...

Besides cancer, researchers across the country are working with microRNA to diagnose and treat Alzheimer’s and viral ...

Reduced Weight Regain: CCT-217 shows promise in preventing weight regain commonly observed after discontinuing incretin ...